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and hypoxia are well documented in patients with 
epilepsy.(1,3) Following this reasoning, a number of 
arguments might be put forward. First, detection 
or exclusion of a pulmonary disease as the cause 
of death can be difficult even at autopsy, because 
forensic autopsy is performed in a considerable 
number of SUDEP cases.(1) Increased lung weight, 
pulmonary congestion and edema have frequently 
been observed in postmortem examinations of 
SUDEP victims.(4) Second, seizure-associated 
respiratory involvement, due to apnea, could be 
considered a prominent feature in SUDEP cases. 
In an elegant study evaluating ictal cardiorespi-
ratory changes in adults with epilepsy,(5) apnea 
lasting at least 10 seconds occurred in 60% of 
patients and was postictal in 40% of the recorded 
seizures. Although apnea was central in all 
10 of the patients evaluated, obstructive apnea 
was observed in only 3. The majority of studies 
of cardiorespiratory function have focused on 
changes during seizures. However, our research 
group recently investigated whether epilepsy 
influences basal respiratory parameters in patients 
with temporal lobe epilepsy during the interictal 
period.(6) Although our study did not identify any 
specific respiratory abnormality in temporal lobe 
epilepsy patients during the interictal period, we 
believe that clinical data related to pulmonary 
disorders in individuals with epilepsy should be 
better investigated.(6) Understanding the cardi-
orespiratory mechanism involved in SUDEP could 
be a key to prevention. One pathogenetic mecha-
nism of SUDEP apnea could be epileptic activity 
transmitted to the cerebral respiratory centers,(1) 
culminating in a lethal vicious cycle of events.(4) 
It has been proposed that brainstem respiratory 
activity is suppressed directly by seizure activity or 
indirectly by hypoxia from ictal cardiac arrest.(4)
We are in total agreement with sugges-
tions that it would be interesting to determine 
whether cardiorespiratory comorbidity is higher 
among epilepsy patients than in the general 
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that SUDEP is responsible for 7.5% to 17% of all 
deaths in epilepsy and has an incidence among 
adults between 1:500 and 1:1,000 patient-
years.(2) SUDEP is defined by precise criteria 
approved in 1997 by an expert panel as sudden, 
unexpected, witnessed or unwitnessed, nontrau-
matic and nondrowning death in patients with 
epilepsy, with or without evidence of a seizure 
and excluding documented status epilepticus, in 
which postmortem examination does not reveal a 
toxicological or anatomical cause of death.(3)
Although results are not wholly consistent 
among studies, a number of factors have 
been reported to be associated with SUDEP. 
Such factors include refractoriness of the 
epilepsy, presence of generalized tonic-clonic 
seizures, polytherapy with antiepileptic drugs, 
younger age, duration of the seizure disorder 
ranging from 15 to 20 years and early onset of 
epilepsy.(1) The pathophysiological mechanisms 
of SUDEP remain unknown. However, it is highly 
likely that certain pulmonary abnormalities 
play a role.(1) Over the past two decades, major 
advances have been made concerning SUDEP. 
However, our understanding of the exact mech-
anisms underlying SUDEP, as well as of the best 
way to prevent it, is still incomplete.
A diagnosis of SUDEP indicates that no cause 
of death was identified. In this sense, a better 
understanding of the mechanisms of SUDEP is 
essential. Although the cause of death in SUDEP 
remains unknown, a number of postmortem, 
ictal and interictal pulmonary changes indicate 
the possibility of seizure-induced pulmonary 
SUDEP.(1,3) Respiratory abnormalities such as 
pulmonary edema, central and obstructive apnea 
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population, as well as whether the prevalence 
of cardiorespiratory comorbidity differs between 
epilepsy patients with and without known risk 
factors for SUDEP.(1) In view of the deficien-
cies in the current knowledge, we believe that 
there is an urgent need for large-scale, prospec-
tive, international, community-based studies of 
cardiorespiratory abnormalities in patients with 
epilepsy to explore risk factors in more detail so 
that preventive strategies can be planned. To 
that end, we are certain that a point of conver-
gence between pulmonologists and neurologists 
could be identified within this clinical context.
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